http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005000815-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fc71568971280f7d43793fa039828f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a70b05f3bdf7f6e9aaf7a41ac3aacdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94eef53549500cd7867b68f4906bd382
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2231fbe2564aded1b09f110e3eef8e7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-46
filingDate 2004-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d722f01036fb33838772730067aec151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43ea93f476d0f8e32e57654703c7d6f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_589245e8f98dca123dd5452ec739d3b6
publicationDate 2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005000815-A3
titleOfInvention Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor
abstract Compounds of formula (I) in salt or zwitterionic form wherein, wherein R1, R2, R3, R4, R5, J, L and M have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
priorityDate 2003-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5679688-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03087094-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1302458-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5283763-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S58208270-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9206958-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0073645-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3613359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559275

Total number of triples: 42.